These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7449122)

  • 21. Development and Evaluation of a Logical Delta Check for Identifying Erroneous Blood Count Results in a Tertiary Care Hospital.
    Miller I
    Arch Pathol Lab Med; 2015 Aug; 139(8):1042-7. PubMed ID: 26230597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus.
    Spielberg F; Kabeya CM; Ryder RW; Kifuani NK; Harris J; Bender TR; Heyward WL; Quinn TC
    Lancet; 1989 Mar; 1(8638):580-4. PubMed ID: 2564112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting false positives in multielement designs: implications for brief assessments.
    Bartlett SM; Rapp JT; Henrickson ML
    Behav Modif; 2011 Nov; 35(6):531-52. PubMed ID: 21873369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of eye position versus computer identified microcalcification clusters on mammograms.
    Krupinski EA; Nishikawa RM
    Med Phys; 1997 Jan; 24(1):17-23. PubMed ID: 9029538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of patients with acute kidney injury by the clinical laboratory using rises in serum creatinine: comparison of proposed definitions and a laboratory delta check.
    Garner AE; Lewington AJ; Barth JH
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):59-62. PubMed ID: 22130632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotazyme assay in neonates without diarrhea. Results of screening survey and preliminary analysis of false positive specimens.
    Rand KH; Houck HJ; Swingle HM
    Am J Clin Pathol; 1985 Dec; 84(6):748-51. PubMed ID: 3000163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concepts and practices in the evaluation of clinical chemistry methods: IV. Decisions of acceptability.
    Westgard JO; de Vos DJ; Hunt MR; Quam EF; Garber CC; Carey RN
    Am J Med Technol; 1978 Jul; 44(7):727-42. PubMed ID: 677164
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast specimen radiography: can it predict margin status of excised breast carcinoma?
    Goldfeder S; Davis D; Cullinan J
    Acad Radiol; 2006 Dec; 13(12):1453-9. PubMed ID: 17138112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cluster-level statistical inference in fMRI datasets: The unexpected behavior of random fields in high dimensions.
    Bansal R; Peterson BS
    Magn Reson Imaging; 2018 Jun; 49():101-115. PubMed ID: 29408478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a clinical laboratory computer to warn of possible drug interference with test results.
    Groves WE; Gajewski WH
    Comput Programs Biomed; 1978 Sep; 8(3-4):275-82. PubMed ID: 755606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concepts and practices in the evaluation of clinical chemistry methods. V. Applications.
    Westgard JO; de Vos DJ; Hunt MR; Quam EF; Carey RN; Garber CC
    Am J Med Technol; 1978 Aug; 44(8):803-13. PubMed ID: 360840
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing diagnostic tests once an optimal cutoff point has been selected.
    Linnet K; Brandt E
    Clin Chem; 1986 Jul; 32(7):1341-6. PubMed ID: 3719943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized Delta Check Rules for Detecting Misidentified Specimens in Children.
    Tan RZ; Markus C; Choy KW; Doery JCG; Loh TP
    Am J Clin Pathol; 2020 Apr; 153(5):605-612. PubMed ID: 31889173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy in clinical chemistry.
    Caraway WT
    Clin Chem; 1971 Feb; 17(2):63-71. PubMed ID: 4926374
    [No Abstract]   [Full Text] [Related]  

  • 36. Practical delta check limits for tumour markers in different clinical settings.
    Yu S; Shin KH; Shin S; Lee H; Yoo SJ; Jun KR; Shin H; Kim S
    Clin Chem Lab Med; 2023 Sep; 61(10):1829-1840. PubMed ID: 36994761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive power of the polygraph: can the "lie detector" really detect liars?
    Brett AS; Phillips M; Beary JF
    Lancet; 1986 Mar; 1(8480):544-7. PubMed ID: 2869271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AIDS -- how false positives affect Africa.
    New Afr; 1996 Sep; (344):14-5. PubMed ID: 12291688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Streptomycin interference in Jaffe reaction - possible false positive creatinine estimation in excessive dose exposure.
    Syal K; Srinivasan A; Banerjee D
    Clin Biochem; 2013 Jan; 46(1-2):177-9. PubMed ID: 23123914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria.
    Lin J; Fernandez H; Shashaty MG; Negoianu D; Testani JM; Berns JS; Parikh CR; Wilson FP
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1723-31. PubMed ID: 26336912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.